Background
==========

Epidemiologic studies have reported a negative relation between sunlight exposure and risk of breast cancer. The hypothesized mechanism for this relationship is sunlight (ultraviolet B)--induced dermal synthesis of vitamin D, which experimental and nonexperimental evidence suggests may reduce risk of several cancers, including breast cancer. Dermal synthesis is the primary source of vitamin D for most individuals, with diet and supplements generally being minor contributors ([@r27]). In dermal synthesis, 7-dehydrocholesterol in the skin is converted to vitamin D~3~, which is then hydroxylated in the liver to the prohormone 25-hydroxy vitamin D \[25(OH)D\], the principal circulating form of vitamin D. 25(OH)D is converted primarily in the kidneys to 1,25-dihydroxyvitamin D \[1,25(OH)~2~D\], the biologically active form of vitamin D, which exerts a range of anticarcinogenic effects ([@r27]; [@r34]). Thus, sunlight and other factors that affect circulating levels of 25(OH)D may influence cancer risk.

Most cohort and case--control studies that have examined sunlight and/or ultraviolet light (UV) exposure---either through self-reported personal behaviors or via ambient levels at place of residence---have reported evidence of a negative association with breast cancer ([@r5]; [@r15]; [@r30], [@r31]; [@r32]; [@r41]; [@r58]). In addition, several ecologic studies have reported negative correlations between measures of sunlight exposure (based on latitude, regional monitoring data, or acid haze) and breast cancer incidence ([@r23]; [@r43]) or mortality ([@r19]; [@r20]; [@r22], [@r23]). Results from studies of serum 25(OH)D levels and breast cancer risk have been inconsistent, which may be due to differences in the timing of serum 25(OH)D measurement relative to cancer diagnosis ([@r18]); the inadequacy of a single blood sample in many populations for assessing individuals' usual circulating 25(OH)D levels, which vary by season and possibly over years ([@r48]); or to the possibility of false-positive findings in some studies.

1,25(OH)~2~D exerts most of its known physiological effects through binding to the vitamin D receptor (VDR) ([@r34]). The VDR, which is expressed in normal breast tissue and most breast tumors ([@r55]), regulates transcription of genes involved in cellular growth, differentiation, apoptosis, angiogenesis, and metastasis ([@r24]; [@r34]; [@r38]). Experimental studies on mammary tumor cell lines from *VDR*-knockout mice have shown that VDR is necessary for 1,25(OH)~2~D to induce cell cycle arrest and apoptosis in breast cancer cells ([@r59]). In addition, the susceptibility of breast and other tissues to tumorigenesis was reported to be increased in VDR-deficient mice ([@r8]). The VDR is encoded by a large gene containing 14 exons that span approximately 75 kb ([@r10]; [@r42]).

In the present study we investigated the risk of breast cancer in relation to sun exposure and its interaction with *VDR* gene variants among wives of farmers in a large, prospective, two-state agricultural cohort. This population has a very wide range of sun exposure; detailed, prospective data on demographic, lifestyle, and occupational factors; and a high rate of follow-up. This research was motivated in part by previous reports of reduced risks of breast cancer among female farmers and agricultural workers relative to the general population ([@r11]; [@r17]; [@r47]; [@r57]).

Methods
=======

*Study population*. Participants were wives of private pesticide applicators, mainly farmers, from Iowa and North Carolina who enrolled in the prospective Agricultural Health Study (AHS) cohort between 1993 and 1997 ([@r3]). A total of 32,127 wives (75% of those eligible) enrolled in the cohort via self-administered questionnaire. Cancer cases were identified through population-based cancer registries in Iowa and North Carolina, and vital status was ascertained through state death registries and the National Death Index (<http://www.cdc.gov/nchs/ndi.htm>). Estrogen receptor (ER) and progesterone receptor (PR) status of the tumor was available from the registries for 475 (82.2%) and 447 (77.3%) cases, respectively. Excluding 1,106 wives with a malignant cancer diagnosis other than nonmelanoma skin cancer before enrollment left 31,021 participants for the present cohort analyses. Among these, 578 were diagnosed with malignant breast cancer \[*International Classification of Diseases for Oncology, 2nd edition* ([@r46]), codes C50.0--C50.9\] between enrollment and 31 December 2004. In addition, 23,676 wives (74% of those enrolled) completed a follow-up telephone interview approximately 5 years after enrollment, at which time approximately 60% provided a mouthwash rinse sample for extraction of buccal cell DNA. More than 98% of the wives in this cohort were white, and 99% were non-Hispanic. The nested case--control study included 293 incident breast cancer cases with a mouthwash sample (50.7% of eligible cases) and two controls with mouthwash samples who were randomly matched with replacement to each case by race (white, Hispanic and non-Hispanic; other), state (Iowa, North Carolina), age at enrollment (5-year age groups), and enrollment period (1993--1995, 1996--1997). In addition, on the diagnosis date of a given case, eligible controls also had to be alive, have no cancer diagnoses, and be living in the same state as the case. A total of 879 cases and controls were selected. Because controls were selected with replacement, which provides an unbiased sample from the cohort ([@r51]), 19 participants were each selected as controls for 2 cases, and 4 participants were each selected as both a control and, at a later time point, a case. Cohort members who returned a mouthwash sample were similar to those who did not with regard to a range of demographic, lifestyle, and medical factors, suggesting that selection bias related to provision of a biospecimen is unlikely to substantially influence estimated associations ([@r14]). Only 263 women (0.8% of all participants) were lost to follow-up. The average follow-up duration was 8.6 years. Participants provided informed consent for the AHS. The institutional review boards of the National Institutes of Health and its contractors approved the AHS. The institutional review boards of Memorial Sloan-Kettering Cancer Center and the University of North Carolina at Chapel Hill approved the present study.

*Exposure assessment*. All sun exposure information was obtained at cohort enrollment. Questions included *a*) "In the growing season, how many hours a day do you generally spend in the sun?" at enrollment and also 10 years before enrollment, with choices of \< 1, 1--2, 3--5, 6--10, \> 10 hr/day, and *b*) "In the growing season when you work in the sun, what type(s) of sun protection do you usually use?" with choices of sunscreen/sunblock, baseball-type cap, other kind of hat with brim, long-sleeved shirt, or none of the above. The questionnaires also elicited information on a range of demographic, lifestyle, health, agricultural, and reproductive factors. Prediagnostic data on menopausal status and age at menopause were also obtained from 5-year follow-up interviews. (Questionnaires are available at <http://www.aghealth.org>.)

*Genotyping in the nested case--control study*. Twenty-six single nucleotide polymorphisms (SNPs) in *VDR* \[rs2544038, rs739837, rs731236 (TaqI), rs2239182, rs2107301, rs2239181, rs2238139, rs2189480, rs3782905, rs7974708, rs11168275, rs2408876, rs1989969, rs2238135, rs10875694, rs3922882, rs11168287, rs7299460, rs11168314, rs4073729, rs3923693, rs4760674, rs6823, rs2071358, rs7975232 (ApaI), rs2228570 (FokI)\] were genotyped, as described in our related work ([@r13]). The *VDR* haplotype structure of our study population was comparable to that observed among whites by [@r44], so linkage disequilibrium blocks were defined using the naming convention of [@r44].

*Data analysis*. We estimated associations between breast cancer and usual sun exposure, both at enrollment and 10 years before enrollment, using the five exposure categories specified in the questionnaire. For the nested case--control analyses, the upper two categories were combined because of small sample numbers. The lowest category (\< 1 hr/day) was used as the reference category in all analyses. The majority of women (84.5%) reported the same levels of sun exposure during the two time periods. Therefore, we estimated associations according to time period using separate models and did not create a composite exposure estimate. We also estimated the association between breast cancer and sun exposure for ≥ 1 hr/day compared with \< 1 hr/day.

Cohort study of sun exposure. We used Cox proportional hazards regression to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between breast cancer and each measure of sunlight exposure. Person-years at risk for each participant were calculated from date of enrollment until the earliest of the following: first breast cancer diagnosis, first malignant non-breast cancer diagnosis (excluding nonmelanoma skin cancer), movement out of state, death, or 31 December 2004. All analyses were adjusted for known breast cancer risk factors, including age (\< 40, 40--49, 50--59, 60--69, ≥ 70 years), race (white, Hispanic and non-Hispanic; other), age at menopause (premenopausal, \< 45, 45--49, 50--54, ≥ 55 years, with status allowed to change during follow-up, based on self-reported age at which participant had her last menstrual period), and first-degree family history of breast cancer (yes, no). Analyses were additionally adjusted for state (Iowa, North Carolina) and for combined parity and age at first birth (1 birth, by age 30 years; ≥ 2 births, first by age 30 years; nulliparous or all births after age 30 years), with nulliparous women and those with first births after age 30 years combined because of the small number of nulliparous cases (*n* = 6). Body mass index, age at menarche, smoking status, and education were not included in the final models because they did not change risk estimates by at least 10%. Time-varying covariates (menopausal status, age at menopause) were classified at each time point based on the most recent value reported; only values reported before the end of follow-up for each participant were used.

We also performed analyses stratified by ER/PR status, menopausal status at diagnosis, family history of breast cancer, and usual use of sunscreen. We included only women with non-missing data for a given stratification factor, including all noncases in each analysis by ER/PR status and menopausal status.

Nested case--control study of sun exposure and gene--environment interaction. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% CIs for usual sun exposure and interactions with genetic variants. Because the genotype data were unphased, we estimated expected haplotypes and their frequencies using the haplo.stats software ([@r52]) in R, version 2.3 (R Foundation for Statistical Computing, Vienna, Austria). We used these as independent variables in regression models ([@r33]) together with sun exposure (\< 1 hr/day, ≥ 1 hr/day) and a product term. We examined only the most common 50% of haplotypes in each linkage disequilibrium block, comprising six haplotypes in block B and seven haplotypes in block C ([@r13]) (see Supplemental Material, Table S2). We present interaction results in the tables only for SNPs and haplotypes that either had significant main effects in univariate analyses (*p* \< 0.05) or showed evidence of departure from multiplicativity in interaction analyses. The multiplicative interaction between sun exposure and each SNP was evaluated via the statistical significance (*p* \< 0.05) of the likelihood ratio test comparing the models with and without the product term. All analyses were adjusted for age at menopause, combined parity and age at first birth, and first-degree family history of breast cancer, as described above, based on status at enrollment.

There was insufficient DNA for genotyping for 23 cases and 32 controls. To account for missing genotype and sun exposure data, we used the missing-indicator method ([@r29]) in our analysis of gene--sun interactions. This method allows all participants to be included in analyses and maintains case--control matching, and produces an OR estimate that is a compromise (i.e., a weighted average) between the estimates from a matched analysis of complete sets and an unmatched analysis of incomplete sets. Analysis confirmed lack of heterogeneity in ORs between complete sets and incomplete sets, which is necessary for the validity of this method ([@r29]).

In both the cohort and the case--control analyses, missing data for adjustment covariates were imputed using IVEware (Institute for Social Research, University of Michigan, Ann Arbor, MI). This program, which assumes an ignorable-missing-data mechanism, simultaneously imputes values for specified variables by fitting a sequence of regression models and drawing values from the corresponding predictive distributions. Missing values were imputed for race (3.2%), family history of breast cancer (5.0%), parity (17.6%), and age at menopause (2.0%). Risk estimates including imputed data were not materially different from those including only observed data, so we present risk estimates adjusted using the imputed and observed data.

All statistical analyses were performed using SAS, version 9.1 (SAS Institute Inc., Cary, NC), except where otherwise noted. Statistical significance was assessed at the 5% level. Tests for trend were assessed using midpoints of categories as continuous measures. In analyses of covariate risk ([Table 1](#t1){ref-type="table"}; see also Supplemental Material, Table S1), all covariates were adjusted for the other covariates, except where indicated, and with no imputed data. We did not adjust *p*-values for multiple comparisons because of the exploratory nature of our genetic analyses. Analyses were based on AHS data releases P1REL0506.01 and P2REL0506.04.

###### 

Selected characteristics at enrollment of wives in the AHS cohort \[cases (*n* = 578), noncases (*n* = 30,443)\].

  Characteristic                                 Cases \[*n* (%)\]   Non­cases \[*n* (%)\].   Adjusted HR^*a*^(95% CI)
  ---------------------------------------------- ------------------- ------------------------ --------------------------
  Age (years)                                                                                 
  18--39                                         55 (9.5)            9,747 (32.0)             1 (Reference)
  40--49                                         141 (24.4)          8,775 (28.8)             2.8 (2.1, 3.9)
  50--59                                         214 (37.0)          7,025 (23.1)             5.6 (4.0, 8.0)
  60--69                                         127 (22.0)          3,938 (12.9)             6.2 (4.2, 9.2)
  70--86                                         41 (7.1)            958 (3.2)                8.6 (5.4, 13.7)
  Race                                                                                        
  White (Hispanic and non-Hispanic)              547 (98.2)          28,962 (98.2)            1 (Reference)
  Other                                          10 (1.8)            517 (1.8)                0.9 (0.5, 1.8)
  Missing                                        21                  964                      
  State of residence                                                                          
  Iowa                                           362 (62.6)          20,469 (67.2)            1 (Reference)
  North Carolina                                 216 (37.4)          9,974 (32.8)             1.1 (0.9, 1.3)
  Highest educational level                                                                   
  \< High school                                 30 (6.0)            1,435 (5.4)              0.7 (0.5, 1.1)
  High school                                    223 (44.2)          10,604 (40.1)            0.9 (0.8, 1.1)
  \> High school                                 251 (49.8)          14,412 (54.5)            1 (Reference)
  Missing                                        74                  3,992                    
  Smoking                                                                                     
  Never                                          394 (73.1)          20,772 (72.4)            1 (Reference)
  Former                                         105 (19.5)          4,925 (17.2)             1.2 (0.9, 1.7)
  Current                                        40 (7.4)            3,003 (10.5)             1.3 (0.9, 1.9)
  Missing                                        39                  1,743                    
  First-degree family history of breast cancer                                                
  Yes                                            114 (20.9)          3,289 (11.4)             1.8 (1.4, 2.2)
  No                                             431 (79.1)          25,643 (88.6)            1 (Reference)
  Missing                                        33                  1,511                    
  Body mass index (kg/m^2^)                                                                   
  \< 25.0                                        191 (44.6)          10,417 (50.6)            1 (Reference)
  25.0--29.9                                     143 (33.4)          6,472 (31.4)             1.0 (0.8, 1.2)
  ≥ 30.0                                         94 (22.0)           3,709 (18.0)             1.2 (1.0, 1.6)
  Missing                                        150                 9,845                    
  Age at menarche (years)                                                                     
  \< 12                                          54 (13.4)           2,790 (15.4)             1 (Reference)
  12--14                                         315 (78.0)          13,710 (75.5)            0.9 (0.7, 1.2)
  ≥ 15                                           35 (8.7)            1,656 (9.1)              1.0 (0.7, 1.4)
  Missing                                        174                 12,287                   
  Parity                                                                                      
  Nulliparous                                    6 (1.2)             621 (2.5)                0.9 (0.4, 2.0)
  1                                              54 (10.7)           2,359 (9.4)              1.2 (0.9, 1.7)
  ≥ 2                                            444 (88.1)          22,075 (88.1)            1 (Reference)
  Missing                                        74                  5,388                    
  Age at first birth (years)^*b*^                                                             
  ≤ 20                                           91 (24.8)           3,889 (23.4)             1 (Reference)
  20--30                                         239 (65.1)          11,700 (70.3)            1.0 (0.7, 1.2)
  \> 30                                          37 (10.1)           1,044 (6.3)              1.8 (1.2, 2.6)
  Missing                                        131                 7,801                    
  Menopausal status                                                                           
  Post­menopausal                                325 (64.5)          11,054 (43.0)            0.9 (0.7, 1.1)
  Pre­menopausal                                 179 (35.5)          14,663 (57.0)            1 (Reference)
  Missing                                        74                  4,726                    
  Age at menopause (years)^*c*^                                                               
  \< 45                                          102 (32.2)          4,249 (39.2)             1 (Reference)
  45--49                                         81 (25.6)           2,659 (24.5)             1.0 (0.7, 1.3)
  50--54                                         107 (33.8)          3,085 (28.5)             1.1 (0.8, 1.4)
  ≥ 55                                           27 (8.5)            846 (7.8)                1.0 (0.6, 1.5)
  Missing                                        8                   215                      
  Usual sunblock use at enrollment                                                            
  Yes                                            242 (41.9)          12,943 (42.5)            1.0 (0.8, 1.2)
  No                                             336 (58.1)          17,500 (57.5)            1 (Reference)
  Tumor ER status                                                                             
  ER^+^                                          315 (75.0)          NA                       
  ER^--^                                         105 (25.0)          NA                       
  Missing                                        158                                          
  Tumor PR status                                                                             
  PR^+^                                          280 (67.3)          NA                       
  PR^--^                                         136 (32.7)          NA                       
  Missing                                        162                                          

Results
=======

Selected characteristics of the women in the cohort and in the nested case--control study are provided in [Table 1](#t1){ref-type="table"} (see also Supplemental Material, Table S1). Most of the women in the cohort (60.3%) were under 50 years of age at enrollment, although, as expected, cases were on average older than noncases/controls. Over 67% of the participants lived in Iowa. Almost all of the women (97.5%) had had at least one birth and about 43% were postmenopausal at enrollment. Distributions of most demographic and lifestyle factors were similar for the 578 cases in the cohort ([Table 1](#t1){ref-type="table"}) and the 293 cases included in the nested case--control study (see Supplemental Material, Table S1). However, a slightly larger proportion of cases in the nested case--control study than in the cohort were from Iowa (66.9% vs. 62.6%) and had education beyond high school (54.8% vs. 49.8%). Approximately 98% of both the cohort and the case--control sample were white.

*Sun exposure*. The range of sun exposure during the growing season among study participants was very wide ([Table 2](#t2){ref-type="table"}). Usual sun exposure of ≥ 6 hr/day was reported by 12.4% of participants who provided information on sun exposure for the period around enrollment and by 21.8% of those who provided information for the period 10 years before enrollment, whereas 27.0% and 17.9% reported \< 1 hr/day for each of these periods, respectively. Sun exposure data were missing for 29--33% of the participants.

###### 

Sunlight exposure and breast cancer risk among wives in the cohort \[cases (*n* = 578), noncases (*n* = 30,443)\] and in the nested case--control study \[cases (*n* = 293), noncases (*n* = 586)\].

  Characteristic                                                   Cohort       Nested case--­control study                                              
  ---------------------------------------------------------------- ------------ ----------------------------- ---------------- ------------ ------------ ----------------------
  Usual hours of sun exposure per day at enrollment                                                                                                      
  \< 1 hr                                                          139 (30.8)   5,804 (26.9)                  1 (Reference)    78 (31.5)    142 (29.9)   1 (Reference)
  1--2 hr                                                          136 (30.2)   6,962 (32.3)                  0.9 (0.7, 1.1)   71 (28.6)    148 (31.2)   0.8 (0.5, 1.2)
  3--5 hr                                                          125 (27.7)   6,129 (28.4)                  0.9 (0.7, 1.2)   72 (29.0)    123 (25.9)   1.0 (0.7, 1.6)
  6--10 hr                                                         43 (9.5)     2,156 (10.0)                  0.9 (0.7, 1.3)   21 (8.5)     52 (10.9)    0.8^^(0.4, 1.3)^*b*^
  \> 10 hr                                                         8 (1.8)      521 (2.4)                     0.7 (0.3, 1.4)   6 (2.4)      10 (2.1)     
  \< 1 hr                                                          139 (30.8)   5,804 (26.9)                  1 (Reference)    78 (31.5)    142 (29.9)   1 (Reference)
  ≥ 1 hr                                                           312 (69.2)   15,768 (73.1)                 0.9 (0.7, 1.1)   170 (68.5)   333 (70.1)   0.9 (0.6, 1.2)
  Missing                                                          127          8,871                                          45           111          
  Usual hours of sun exposure per day 10 years before enrollment                                                                                         
  \< 1 hr                                                          92 (21.7)    3,592 (17.8)                  1 (Reference)    57 (24.4)    88 (19.3)    1 (Reference)
  1--2 hr                                                          103 (24.3)   5,224 (25.8)                  0.8 (0.6, 1.1)   54 (23.1)    103 (22.6)   0.7 (0.5, 1.2)
  3--5 hr                                                          133 (31.4)   6,967 (34.5)                  0.8 (0.6, 1.0)   74 (31.6)    154 (33.8)   0.7 (0.5, 1.1)
  6--10 hr                                                         75 (17.7)    3,569 (17.6)                  0.8 (0.6, 1.1)   36 (15.4)    88 (19.3)    0.6^^(0.4, 1.0)^*c*^
  \> 10 hr                                                         20 (4.7)     869 (4.3)                     0.9 (0.5, 1.4)   13 (5.6)     22 (4.8)     
  \< 1 hr                                                          92 (21.7)    3,592 (17.8)                  1 (Reference)    57 (24.4)    88 (19.3)    1 (Reference)
  ≥ 1 hr                                                           331 (78.3)   16,629 (82.2)                 0.8 (0.6, 1.0)   177 (75.6)   367 (80.7)   0.7 (0.5, 1.0)
  Missing                                                          155          10,222                                         59           131          

We found little evidence of a decreasing dose--response relation between usual sun exposure and breast cancer risk for exposure either at enrollment or 10 years before enrollment ([Table 2](#t2){ref-type="table"}). However, we observed a small decreased risk associated with usual sun exposure of ≥ 1 hr/day compared with \< 1 hr/day 10 years before enrollment (HR = 0.8; 95% CI: 0.6, 1.0) in the cohort, with similar associations for participants in Iowa (HR = 0.7; 95% CI: 0.5, 1.0) and North Carolina (HR = 0.8; 95% CI: 0.6, 1.2). At least 75% of North Carolina participants and 84% of Iowa participants resided in the same state 10 years before enrollment. As expected, patterns of association were similar between women in the cohort and women in the nested case--control study.

Negative associations with sun exposure appeared to be limited to women with no family history of breast cancer (for sun exposure ≥ 1 hr/day vs. \< 1 hr/day 10 years before enrollment, HR = 0.7; 95% CI: 0.6, 0.9 and 1.2; 95% CI: 0.6, 2.1 among women without and with a family history, respectively) ([Table 3](#t3){ref-type="table"}). The negative association with sun exposure also appeared to be limited to women with ER^+^ tumors \[for sun exposure ≥ 1 hr/day versus \< 1 hr/day 10 years before enrollment, HR = 0.7; 95% CI: 0.5, 0.9 and 1.1; 95% CI: 0.6, 2.1 for ER^+^ (*n* = 315) and ER^--^ (*n* = 105) tumors, respectively\]. We observed no evidence of differences in associations by menopausal status, usual use of sunscreen/sunblock, or PR status of the tumor ([Table 3](#t3){ref-type="table"}).

###### 

HRs for sunlight exposure ≥ 1 hr/day and breast cancer risk among wives in the cohort, stratified by selected factors \[cases (*n* = 578), noncases (*n* = 30,443)\].

  Characteristic                    Cases (*n*)   Noncases (*n*)   Usual hours of sun exposure per day at enrollment \[adjusted HR^*a*^ (95% CI)\]   Usual hours of sun exposure per day 10 years before enrollment \[adjusted HR^*a*^ (95% CI)\]
  --------------------------------- ------------- ---------------- --------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------
  Menopausal status                                                                                                                                  
  Premenopausal                     179           14,663           1.0 (0.7, 1.4)                                                                    0.8 (0.5, 1.1)
  Postmenopausal                    325           11,054           0.9 (0.7, 1.1)                                                                    0.8 (0.6, 1.1)
  Usual use of sunscreen/sunblock                                                                                                                    
  Yes                               242           12,943           0.9 (0.7, 1.1)                                                                    0.7 (0.5, 1.0)
  No                                336           17,500           0.9 (0.7, 1.2)                                                                    0.8 (0.6, 1.2)
  Family history of breast cancer                                                                                                                    
  Yes                               114           3,289            1.3 (0.8, 2.1)                                                                    1.2 (0.6, 2.1)
  No                                431           25,643           0.8 (0.7, 1.1)                                                                    0.7 (0.6, 0.9)
  Tumor ER status                                                                                                                                    
  ER^+^                             315           NA               0.9 (0.7, 1.2)                                                                    0.7 (0.5, 0.9)
  ER^--^                            105           NA               0.7 (0.4, 1.1)                                                                    1.1 (0.6, 2.1)
  Tumor PR status                                                                                                                                    
  PR^+^                             280           NA               0.9 (0.7, 1.2)                                                                    0.7 (0.5, 1.0)
  PR^--^                            136           NA               0.7 (0.5, 1.1)                                                                    0.8 (0.5, 1.2)

Adjustment for self-reported duration of pesticide use and self-reported measures of occupational and recreational physical activity from the enrollment questionnaire did not materially alter risk estimates (data not shown). Results were also similar in subanalyses restricted to whites (data not shown), which was expected given the small proportion of nonwhites in this study.

*Gene--environment interactions*. [Tables 4](#t4){ref-type="table"} and [5](#t5){ref-type="table"} present results for only the five SNPs and three haplotypes, respectively, that either had significant main effects in univariate analyses (*p* \< 0.05) or showed evidence of departure from multiplicativity in interaction analyses. The interaction between rs2239181 and usual sun exposure 10 years before enrollment on breast cancer risk showed some evidence of a departure from multiplicativity ([Table 4](#t4){ref-type="table"}). Among those with the T/T genotype at rs2239181, usual sun exposure ≥ 1 hr/day was associated with a 30% decrease in the odds of breast cancer (OR = 0.7; 95% CI: 0.4, 1.1) relative to usual sun exposure \< 1 hr/day. In contrast, among those with T/G or G/G genotypes (combined), usual sun exposure ≥ 1 hr/day was associated with only a 14% decrease in the odds of breast cancer relative to those with usual sun exposure \< 1 hr/day (OR = 1.2 vs. OR = 1.4; interaction *p*-value = 0.06). We found no evidence of departure from multiplicativity between other SNPs and usual sun exposure 10 years before enrollment.

###### 

Selected interactions between genetic polymorphisms and usual sun exposure 10 years before enrollment on breast cancer risk among wives in the nested case--control study \[cases (*n* = 293), noncases (*n* = 586)\].^*a*^

  Genotype     Sun exposure (hr/day)   Cases(*n*^*b*^)   Controls(*n*^*b*^)   Adjusted OR^*c*^(95% CI)   *p*‑Value for inter­action^*d*^
  ------------ ----------------------- ----------------- -------------------- -------------------------- ---------------------------------
  rs2544038                                                                                              
  T/T          \< 1                    16                26                   1 (Reference)              
  T/T          ≥ 1                     45                120                  0.5 (0.3, 1.1)             
  T/C          \< 1                    24                45                   0.9 (0.4, 2.0)             
  T/C          ≥ 1                     84                160                  0.8 (0.4, 1.6)             
  C/C          \< 1                    12                11                   1.9 (0.6, 5.4)             
  C/C          ≥ 1                     31                57                   0.9 (0.4, 1.9)             0.12
  rs2239181                                                                                              
  T/T          \< 1                    38                63                   1 (Reference)              
  T/T          ≥ 1                     132               302                  0.7 (0.4, 1.1)             
  T/G or G/G   \< 1                    14                18                   1.4 (0.6, 3.2)             
  T/G or G/G   ≥ 1                     32                44                   1.2 (0.6, 2.3)             0.06
  rs11168287                                                                                             
  A/A          \< 1                    11                23                   1 (Reference)              
  A/A          ≥ 1                     52                87                   1.2 (0.5, 2.6)             
  A/G          \< 1                    29                42                   1.5 (0.6, 3.5)             
  A/G          ≥ 1                     83                175                  0.9 (0.4, 2.0)             
  G/G          \< 1                    12                17                   1.3 (0.5, 3.9)             
  G/G          ≥ 1                     24                71                   0.7 (0.3, 1.6)             0.26
  rs739837                                                                                               
  T/T          \< 1                    14                31                   1 (Reference)              
  T/T          ≥ 1                     56                94                   1.2 (0.6, 2.5)             
  T/G          \< 1                    21                33                   1.3 (0.6, 3.1)             
  T/G          ≥ 1                     75                157                  1.0 (0.5, 1.9)             
  G/G          \< 1                    17                19                   1.8 (0.7, 4.6)             
  G/G          ≥ 1                     33                93                   0.7 (0.3, 1.5)             0.13
  rs7975232                                                                                              
  A/A          \< 1                    14                31                   1 (Reference)              
  A/A          ≥ 1                     56                94                   1.2 (0.6, 2.5)             
  A/C          \< 1                    21                33                   1.3 (0.6, 3.1)             
  A/C          ≥ 1                     77                160                  1.0 (0.5, 1.9)             
  C/C          \< 1                    17                19                   1.8 (0.7, 4.6)             
  C/C          ≥ 1                     32                94                   0.6 (0.3, 1.4)             0.10

###### 

Selected interactions^*a*^ between haplotypes in block B^*b*^ and usual sun exposure 10 years before enrollment on breast cancer risk among wives in the nested case--control study \[cases (*n* = 293), noncases (*n* = 586)\].

  Haplotype         Sun exposure (hr/day)   Adjusted OR^*c*^ (95% CI)   *p*‑Value for inter­action
  ----------------- ----------------------- --------------------------- ----------------------------
  B4: GTCATTTCCTA                                                       
  Not B4            \< 1                    1 (Reference)               
  Not B4            ≥ 1                     0.7 (0.5, 1.1)              
  B4                \< 1                    0.6 (0.2, 1.5)              
  B4                ≥ 1                     0.3 (0.2, 0.5)              0.69
  B5: TCAGCTTACTA                                                       
  Not B5            \< 1                    1 (Reference)               
  Not B5            ≥ 1                     0.7 (0.4, 1.0)              
  B5                \< 1                    0.8 (0.4, 1.5)              
  B5                ≥ 1                     0.7 (0.5, 0.8)              0.51
  B6: TCAGCTTCGCA                                                       
  Not B6            \< 1                    1 (Reference)               
  Not B6            ≥ 1                     0.5 (0.3, 0.9)              
  B6                \< 1                    0.6 (0.4, 1.0)              
  B6                ≥ 1                     0.6 (0.5, 0.7)              0.07

There was a suggestion of sub-multiplicativity between haplotype TCAGCTTCGCA (haplotype "B6") and usual sun exposure ≥ 1 hr/day 10 years before enrollment; however, this was not significant (interaction *p*-value = 0.07) ([Table 5](#t5){ref-type="table"}). Among carriers of the TCAGCTTCGCA haplotype, sun exposure was not associated with the odds of breast cancer: The ORs associated with sun exposure ≥ 1 hr/day and sun exposure \< 1 hr/day were both 0.6. In contrast, among noncarriers of this haplotype, sun exposure was associated with a 50% decrease in breast cancer odds (OR = 0.5; 95% CI: 0.3, 0.9). Results did not differ substantively between subgroups defined by family history of breast cancer or use of sun protection, or in subanalyses restricted to whites (data not shown).

Discussion
==========

Results from this large, prospective cohort study of women living and/or working on farms suggest that sunlight exposure may be associated with a reduced risk of breast cancer, particularly for ER^+^ tumors. The timing of sun exposure may be important because exposure 10 years before start of follow-up was negatively associated with breast cancer, whereas sun exposure at the start of follow-up was not, although this difference could be due to other factors such as missing data. There was some evidence that the association between usual sun exposure and risk of breast cancer was modified by one of the 13 haplotypes evaluated.

Our findings regarding sunlight exposure and breast cancer risk are consistent with most previous studies on this topic. Negative associations have been observed in both case--control studies ([@r5]; [@r32]) and cohort studies ([@r15]; [@r30], [@r31]; [@r41]; [@r58]). Measures of sunlight exposure that have been negatively associated with breast cancer include self-reported time spent outdoors in daylight ([@r5]; [@r30]; [@r32]; [@r41]) and cumulative sun exposure estimates based on reflectometric measurement of skin pigmentation ([@r31]). Extent of sun-seeking vacations and solarium use were negatively associated with breast cancer risk in a cohort of 42,559 Swedish women followed for an average of 14.9 years ([@r58]) but not in a cohort of 41,811 Norwegian women followed for an average of 8.5 years ([@r12]). Ecologic studies, while providing weaker evidence, also have been largely consistent in showing a negative correlation between breast cancer risk and potential UV exposure, based on average ground-level solar energy ([@r19]; [@r21]), latitude ([@r23]), or acid haze ([@r20]). The reason for the observed difference in association by timing of exposure in our study is unclear. Some studies have suggested stronger associations at younger ages ([@r32]; [@r58]), which would be generally consistent with our findings, although other studies have found similar associations across age groups ([@r5]; [@r31]).

We found no evidence of a dose--response relation between self-reported sun exposure ≥ 1 hr/day and breast cancer risk, but the relative risk of breast cancer did appear to be reduced in association with ≥ 1 hr/day of usual sun exposure compared with \< 1 hr/day. The exposure distribution in this occupationally exposed population is likely skewed high compared with general population samples in previous studies. However, once individuals achieve a circulating 25(OH)D level of about 40 ng/mL, the effects of additional sun/UV exposure appear to become blunted, with a much lower rate of increase in circulating 25(OH)D per unit of sun exposure ([@r28]). Self-reported exposure information reflecting usual behavior over a long time period may be too imprecise to measure incremental reductions in risk from longer durations of sun exposure.

We observed no modification of the association between sunlight exposure and breast cancer risk by sunscreen use, which is consistent with the lack of association between sunscreen use and breast cancer risk reported in other studies ([@r5]; [@r32]; [@r35]). This may be due to the fact that many people apply insufficient sunscreen and do not reapply it as frequently as needed ([@r45]). Indeed, sunscreen use can be a poor predictor of 25(OH)D levels ([@r54]).

Evidence that the relationship between vitamin D and breast cancer risk differs by hormone receptor status of the tumor is conflicting. [@r6], in a population-based study of 759 cases and 1,135 controls, observed reduced risks of similar magnitude for ER^+^/PR^+^ tumors, ER^--^/PR^--^ tumors, and ER^+^/PR^--^ tumors associated with increased vitamin D intake via sun and diet. In contrast, a study involving 1,019 incident cases within the prospective Women's Health Study ([@r36]) and another study involving 2,855 incident cases within the prospective Cancer Prevention Study II Nutrition Cohort ([@r39]) reported stronger negative associations between dietary vitamin D intake and both ER^+^ or PR^+^ tumors. However, a study of 2,440 incident cases within the prospective Iowa Women's Health Study observed stronger negative associations with ER^--^ or PR^--^ tumors ([@r49]). *In vitro* studies suggest that ER^+^ breast cancer cell lines are generally more sensitive than ER^--^ cell lines to 1,25(OH)~2~D--mediated growth regulation ([@r56]).

Studies that have examined interactions between *VDR* variants and markers of vitamin D---including sun exposure, serum 25(OH)D, and dietary vitamin D intake---on breast cancer risk have produced inconsistent, but largely null, results. A case--control study of breast cancer reported limited evidence of an interaction between *BsmI* (rs1544410) genotype and serum 25(OH)D concentrations measured in blood samples collected after diagnosis ([@r37]). A case--control study that examined seven of the same polymorphisms as the present study (rs731236, rs739837, rs1989969, rs2228570, rs7975232, rs2107301, rs2238135) found, like the present study, no significant interactions between sun exposure and these polymorphisms ([@r4]). However, [@r4] did observe a significant interaction between dietary vitamin D intake and rs2238135. Other studies have reported no modification of associations between measured or inferred vitamin D status and breast cancer by the *VDR* polymorphisms *BsmI* ([@r9]; [@r40]), *FokI* ([@r1]; [@r9]; [@r31]; [@r40]), *TaqI* ([@r1]; [@r31]; [@r40]), or *ApaI* (rs7975232, also evaluated in the present study) ([@r40]).

Limitations of this study include use of self-reported usual sun exposure, which likely introduced some exposure misclassification. However, studies indicate that reliability of recall of usual or total sun exposure is good, with interclass correlation coefficients of about 0.7--0.8 ([@r16]; [@r50]); that self-reported sun exposure correlates with circulating 25(OH)D levels ([@r26]; [@r53]); and that reliability of reporting for a range of factors among Agricultural Health Study participants is good to excellent, with percent agreements of 50--60% for measures of pesticide use and 71--76% for amount of alcohol and tobacco use ([@r7]). The appreciable amount of missing sun exposure data may have introduced some bias in the present study. About 22% of cases and 29% of noncases were missing data on usual sun exposure at enrollment, whereas 29% of cases and 34% of noncases were missing data on usual sun exposure 10 years before enrollment. The reasons for the differences in percent missing are unclear. However, any exposure misclassification among those who provided sun exposure information in this study is likely nondifferential with regard to disease status because exposure information was collected before breast cancer diagnosis. As in any study, there may also be uncontrolled confounding, although we evaluated a wide range of potential confounders and included any that were found to affect risk estimates. Although the 5-year follow-up interview may have occurred after breast cancer diagnosis for some cases, only covariate data collected before diagnosis for the cases and their matched controls were included in this study. Also, the minimum sun exposure category in the questionnaire was up to 1 hr, and the rate of vitamin D synthesis per amount of sun exposure may decrease within this time period. Nonetheless, evidence suggests that vitamin D levels continue to rise with increasing sun exposure above levels attainable through casual exposure ([@r2]; [@r25]) and our cohort had a very wide range of exposure. Although we examined only sun exposure as a vitamin D source in the present study, sun exposure accounts for the large majority of circulating 25(OH)D in most people ([@r27]). The relatively small sample size of the nested case--control study limited our ability to estimate interactions. In addition, some observed associations may be due to chance because of the number of comparisons performed. Last, the generalizability of this study may be limited primarily to whites because of the small proportion of nonwhites in the study population and differences in vitamin D synthesis by skin color.

Strengths of this study include collection of all information on exposures and covariates before disease diagnosis; thus, any misclassification was likely nondifferential with regard to disease status. In addition, this cohort is large and includes a substantial number of incident cases. Follow-up of this cohort is excellent. Also, this cohort has an unusually wide range of usual sun exposure compared with the general population, with a substantial proportion of women in the upper end of the exposure distribution providing greater exposure contrasts, although no dose--response association was observed. Reliability of reporting for a range of lifestyle and occupational factors is good to excellent in this cohort ([@r7]). Finally, this study had detailed data at baseline and at 5 years on potential confounders and effect modifiers.

Conclusion
==========

Our results suggest that sun exposure may be associated with reduced risk of breast cancer, but we did not find clear evidence of modification of this association by variants in the *VDR* gene. Our results further suggest that this association may be stronger for ER^+^ tumors, although these analyses are based on a relatively small sample size. Larger studies, particularly among populations in which usual sun exposure at the low end can be more precisely characterized, are warranted to help clarify this relationship.

Supplemental Material
=====================

###### 

Click here for additional data file.
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